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Synopsis	
Relapsing	fever	borreliae	were	notorious	and	feared	infectious	agents	that	earned	their	
place	in	history	through	their	devastating	impact	as	causes	of	both	epidemic	and	
endemic	infection.	More	recently	they	are	considered	more	as	an	oddity	and	their	
burden	of	infection	is	largely	overshadowed	by	other	infections	such	as	malaria,	which	
presents	in	a	similar	clinical	way.	Despite	this,	they	remain	the	most	common	bacterial	
infection	in	some	developing	countries.	Transmitted	by	soft	ticks	or	lice,	these	
fascinating	spirochaetes	have	evolved	a	myriad	of	mechanisms	to	survive	within	their	
diverse	environments.	
	
	 	
	 3
Key	Points		
 Most	relapsing	fever	borreliae	are	transmitted	by	soft	ticks	belonging	to	the	
Argasidae	genera.		These	are	rapid‐feeding	ticks	and	their	bites	may	go	
unnoticed.	
 The	epidemic	member	of	this	group,	Borrelia	recurrentis,	is	transmitted	by	the	
human	clothing	louse,	Pediculus	humanus.			
 Most	relapsing	fever	Borrelia	are	zoonotic,	with	the	exception	of	Borrelia	duttonii	
and	Borrelia	recurrentis.		
 Consider	a	relapsing	fever	borreliosis	among	individuals	with	a	relapsing	febrile	
illness	and	travel	history	to	an	endemic	region,	particularly	when	malaria	is	the	
differential	the	diagnosis.	
 Conventional	diagnostic	microbiological	approaches	are	unlikely	to	detect	
relapsing	fever	spirochaetes.	
 Most	infections	are	successfully	managed	with	penicillin,	tetracycline	or	
doxycycline.		The	Jarisch‐Herxheimer	reaction	can	complicate	treatment.	
	
Self‐Test	Questions	
	
What	is	the	time	required	for	agasid	ticks	to	feed	to	repletion?	
a) 5	minutes	to	2	hours	
b) >48	hours	
c) 1‐10	seconds	
d) >7	days	
Which	of	the	following	statements	regarding	relapsing	fever	borreliosis	is	
incorrect?	
a) These	infections	are	acquired	from	arthropods	including	lice	and	ticks	
b) This	infection	is	a	strictly	tropical	disease	
c) Reinfection	can	occur	
d) Infection	can	be	treated	with	antibiotics	such	as	penicillin	or	doxycycline	
Which	of	the	following	relapsing	fever	borreliae	are	not	considered	to	be	
zoonotic?	
a) Borrelia	persica	and	Borrelia	microti	
b) Borrelia	crocidurae	and	Borrelia	hispanica	
c) Borrelia	hermsii	and	Borrelia	turicatae	
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d) Borrelia	recurrentis	and	Borrelia	duttonii	
Borrelia	recurrentis	is	a	believed	to	have	evolved	from	which	of	the	tick‐borne	
relapsing	fever?	
a) Borrelia	hermsii	
b) Borrelia	duttonii	
c) Borrelia	persica	
d) Borrelia	hispanica	
Which	vertebrate	species	is	believed	to	have	an	important	role	in	the	ecology	of	
relapsing	fever	in	California?	
a) Flying	squirrel	
b) Rat	
c) Bats	
d) Chipmunk	
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Historical	Background	
The	term	‘relapsing	fever’	was	first	coined	following	an	outbreak	of	relapsing	
febrile	illness	in	Edinburgh,	UK.	Whilst	Otto	Obermeier	revealed	the	infectious	aetiology	
of	relapsing	fever	in1868,	fulfilment	of	Koch’s	postulates	proved	challenging	due	to	the	
predilection	of	this	spirochaete	for	its	human	host	1.		This	limitation	prevented	
publication	of	his	findings	until	1873,	when	sufficient	additional	evidence	was	
generated	to	substantiate	a	causative	role	for	the	spirochaete.	Mackie	subsequently	
disclosed	the	role	of	the	human	clothing	louse,	Pediculus	humanus,	as	the	vector	
responsible	for	transmission	of	this	infection	in	1907	2.	During	these	times,	epidemic	
louse‐borne	relapsing	fever	(LBRF)	resulted	in	substantial	mortality,	particularly	during	
situations	of	overcrowding	and	poverty	that	favoured	rapid	spread	of	the	organism,	
facilitated	primarily	by	the	clothing	louse	vector.	Massive	outbreaks	resulted	in	millions	
of	cases	throughout	Africa	and	globally	during	World	Wars	I	and	II	3.	
Livingstone	described	another	variant	of	relapsing	fever	in	1857,	this	time	
associated	with	soft	tick	vectors	4.	Both	Ross	and	Milne	and	Dutton	and	Todd	
independently	established	the	role	of	ticks	in	transmitting	this	form	of	relapsing	fever	in	
1904,	with	Dutton	and	Todd	both	becoming	accidentally	infected	themselves	whilst	
undertaking	their	research	5,6.	Dutton	kept	a	temperature	chart	of	his	relapsing	fever	
until	he	succumbed	to	the	illness,	with	the	infectious	agent	being	named	after	him	to	
reflect	his	contribution	to	our	understanding	of	this	infection.	Interestingly,	these	
researchers	drew	the	parallel	between	this	agent	and	its	louse‐borne	variant	and	their	
observations	were	recently	substantiated	by	full	genomic	sequencing	of	both	infectious	
organisms.	
Subsequently,	other	Ornithodoros	soft	ticks	have	been	identified	as	vectors	for	
different	species	of	relapsing	fever	borreliae.	The	majority	of	these	species	appear	to	
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have	adapted	to	a	particular	tick	species,	and	consequently,	many	are	named	after	their	
tick	vectors	(Table	1).		
Classification	
Classification	of	members	within	the	borreliae	was	initially	based	upon	the	type	
of	tick	species	that	serves	as	their	vectors,	with	the	Borrelia	burgdorferi	sensu	lato	
complex	transmitted	by	Ixodes	species	ticks	(hard	ticks),	whilst	the	relapsing	fever	
borreliae	are	transmitted	by	ticks	belonging	to	the	Argasidae	genera	(soft	ticks;	Figure	
1).	More	recently,	this	rather	simplistic	division	has	been	challenged	with	the	finding	
that	Borrelia	miyamotoi	(see	Chapter	10)	and	Borrelia	lonestari	cluster	phylogenetically	
amongst	the	relapsing	fever	Borrelia,	yet	are	transmitted	by	hard	ticks.	Currently,	there	
are	23	validated	relapsing	fever	Borrelia	species,	though	others	are	awaiting	sufficient	
data	to	achieve	such	status,	and	many	of	these	agents	show	a	distinct	preference	for	
transmission	by	a	specific	tick	vector	species.	Borrelia	recurrentis	is	the	notable	
exception	being	transmitted	by	clothing	lice	(P.	humanus).	Table	1	lists	the	majority	of	
currently	accepted	species,	though	several	novel	species	have	recently	been	described,	
including	“B.	mvumii”	in	ticks	from	Tanzania	7,	B.	microti	and	other	species	from	Iran	8,9,	
B.	turicatae‐like	Borrelia	in	bat	ticks	from	the	USA	10,	and	as	of	yet	unnamed	species	
from	penguins	in	South	Africa	11,	though	the	species	status	and	potential	virulence	of	
this	agent	for	humans	remains	to	be	established.		
The	taxonomic	position	of	relapsing	fever	spirochaetes	is	a	matter	of	
controversy.	Application	of	discriminatory	typing	tools	(see	section	on	diagnosis	and	
typing)	has	revealed	clades	within	species	such	as	B.	hermsii.	Others	have	reported	
different	sub‐populations	within	B.	duttonii,	with	all	of	the	cultivable	isolates	falling	into	
just	one	of	four	sub‐types	12.	Conversely,	16S	rRNA	gene	sequencing	has	underscored	
the	similarity	between	some	species	13.	These	similarities	have	been	corroborated	by	
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whole	genomic	sequencing,	which	suggests	that	the	LBRF,	B.	recurrentis,	actually	
represents	a	degraded	sub‐set	of	B.	duttonii	14.	Whilst	sequencing	of	the	closely	related	
zoonotic	B.	crocidurae	that	predominates	in	west	Africa,	has	further	highlighted	how	
conserved	these	three	African	species	are,	despite	their	profound	differences	in	host	
preferences,	severity	and	arthropod	vectors	15.	Based	upon	their	conserved	genomic	
make‐up,	yet	diverse	ecology,	the	above	three	relapsing	fever	Borrelia	may	best	be	
considered	as	ecotypes	of	a	single	species.	
	
Microbiology	
Members	of	this	group	have	a	characteristic	Gram‐negative	helical	structure	with	
3	to10	coils	and	a	length	of	10‐30µm	and	a	width	of	0.2‐0.5µm	16.	Typical	of	this	genus,	
they	have	up	to	30	flagellae	residing	within	the	periplasmic	space	between	the	outer	
membrane	and	protoplasmic	cylinder.	These	endow	a	rapid	gyrating	motility	to	these	
spirochaetes	that	can	be	seen	using	dark‐field	or	phase	microscopy	of	freshly	collected	
specimens	(see	diagnostic	methods	below).		
Porin	proteins	are	found	spanning	the	outer	cell	membrane	and	serve	as	a	
conduit	for	diffusion	of	low‐molecular	weight	compounds.	The	first	of	these	described	
among	relapsing	fever	spirochaetes	was	p66	17.	Others	have	subsequently	been	
described,	such	as	Oms38	which	appeared	to	be	conserved	between	B.	recurrentis,	B.	
duttonii,	B.	hermsii	and	B.	turicatae	18	that	shows	homology	with	the	DipA	porin	found	
among	Lyme‐associated	borreliae	19.	Elucidation	of	such	features	will	provide	insights	
into	the	physiological	characteristics	of	these	spirochaetes	and	might	additionally	
reveal	potential	targets	for	vaccine	development.	
The	outer	membrane	lipid	bilayer	contains	both	lipidated	and	non‐lipidated	
trans‐membrane	proteins.	Much	attention	has	been	focussed	upon	the	relatively	
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abundant	variable	membrane	proteins	(Vmp)	as	these	appear	to	be	pivotal	for	rapidly	
switching	between	and	surviving	within	the	diverse	environments	of	the	arthropod	
vector	and	the	mammalian	host	(see	section	on	pathogenesis	below).	Furthermore,	
these	highly	antigenic	proteins	are	thought	to	contribute	to	the	rapid	switching	from	
arthropod	to	host	environment,	binding	of	host	factors,	adhesion	and	even	tissue	
tropism	20,21.	Vmps	have	been	extensively	studied	as	they	are	subject	to	antigenic	
variation	with	an	estimated	recombination	frequency	of	10‐4	to	10‐3	per	cell	
generations,	providing	a	mechanism	for	evasion	of	the	vertebrate	host	immune	system.	
Such	persistence	mechanisms	are	likely	to	maximise	the	chances	of	transmission	to	
uninfected	arthropod	vectors	from	infected	vertebrates,	thus	providing	a	vital	means	of	
sustainability.		They	can	generally	be	divided	into	one	of	two	groups,	small	Vmps	(also	
called	vsp)	with	molecular	weight	ranging	from	20‐24kDa	or	large	Vmps	(also	called	
vlp)	that	typically	range	from	35‐45kDa	22.	The	small	Vmps	have	been	likened	to	OspC	
of	the	Lyme	disease	spirochaete,	Borrelia	burgdorferi.	This	has	a	key	role	in	the	
transmission	from	arthropod	to	vertebrate	host	and	establishment	of	early	infection.		
Furthermore,	expression	of	different	small	Vmps	within	B.	turicatae	has	been	
demonstrated	to	result	in	either	central	nervous	infection	(vspA)	or	blood‐borne	
disease	(vspB)	with	associated	arthritis	and	myocarditis	in	a	mouse	infection	model	
(see	pathogenesis	section	below).	Expression	of	one	small	Vmp	(vtp	or	vsp33)	has	been	
proposed	as	a	tick	adapted	variant.	The	large	Vmps	can	be	further	sub‐divided	into	one	
of	four	groups	(α,	β,	γ,	δ)	base	upon	their	sequence	homologies.	In	the	author’s	personal	
experience,	human	clinical	isolates	of	B.	recurrentis	and	B.	duttonii	expressed	either	
small	or	large	Vmps	with	no	evidence	of	correlation.	
The	physiological	requirements	of	these	microbes	is	poorly	understood,	however	
their	fastidious	nature	probably	arises	from	their	limited	metabolic	capabilities.	This	
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restricted	biosynthetic	repertoire	necessitates	the	supply	of	amino	acids,	fatty	acids,	
nucleotides	and	enzyme	co‐factors	from	their	surrounding	environment,	whether	this	is	
in	their	arthropod	vector,	the	mammalian	host	or	complex	growth	medium	(see	section	
on	diagnostic	methods).	Whilst	within	the	vertebrate	host,	the	phenomenon	of	
“rosetting”	has	been	noted	and	it	is	hypothesised	that	the	borreliae	are	“grazing”	to	
harvest	essential	nutrients	such	as	purines	from	red	blood	cells	23,24.	Indeed,	unlike	B.	
burgdorferi,	the	relapsing	fever	spirochaetes	contains	a	full	set	of	purine	salvage	genes	
and	demonstrate	efficient	acquisition	and	incorporation	of	hypoxanthine,	the	purine	
catabolic	produce	found	within	red	blood	cells,	that	might	explain	in	part	why	these	
borreliae	achieve	higher	blood	densities	compared	to	the	Lyme	disease	spirochaetes.	
The	genomic	organisation	of	these	spirochaetes	differs	from	conventional	
bacterial	dogma,	as	these	microbes	containing	linear	chromosomes	with	covalently	
closed	telomeres	and	a	combination	of	both	circular	and	linear	plasmids	that	comprise	
approximately	10%	of	the	full	genetic	complement	of	these	microorganisms	25.	The	
majority	of	essential	“house‐keeping”	genes	reside	on	the	chromosome,	whilst	the	
lipoprotein	genes	tend	to	locate	to	the	plasmids	26.		
Whole	genome	sequencing	has	been	undertaken	for	six	relapsing	fever	
spirochaetes	including	B.	hermsii,	B.	parkeri,	B.	turicatae,	B.	crocidurae,	B.	duttonii	and	B.	
recurrentis	(for	further	information	see	“BorreliaBase”	27)	and	will	provide	a	valuable	
resource	to	gain	greater	insight	into	the	underpinning	microbiological	features	of	these	
organisms	28,29.	A	striking	observation	arising	from	the	project	thus	far	has	been	the	lack	
of	any	unique	virulence	features	for	B.	recurrentis	when	compared	to	the	closely	related	
B.	duttonii.	As	indicated	above,	this	has	led	to	the	conclusion	that	rather	than	being	a	
distinctive	species,	B.	recurrentis	is	instead	a	degraded	subspecies	of	B.	duttonii	that	has	
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become	louse‐transmitted,	though	taxonomically	it	is	still	recognised	as	a	separate	
species.	
	
Ecology	and	transmission	
Most	of	the	relapsing	fever	spirochaetes	are	zoonoses	with	vertebrate	reservoirs	
(Table	1).	In	the	majority	of	cases,	these	reservoirs	are	rodents,	however	bats,	birds	and	
reptiles	may	also	play	a	role	in	the	environmental	maintenance	of	these	organisms	30‐33.	
Chipmunks	have	for	example	been	noted	as	a	significant	reservoir	species	for	B.	hermsii	
in	the	Sierra	Nevada	mountains	of	California.	Notably,	for	B.	recurrentis	and	B.	duttonii	
humans	are	the	exclusive	reservoir.	Many	consider	the	tick	vector	to	also	serve	as	a	
reservoir	of	infection	for	tick	borne	relapsing	fever	(TBRF).		This	is	facilitated	by	
transstadial,	and	for	some	species,	transovarial	transmission	of	the	spirochaete	
between	generations.		Additionally,	these	ticks	have	an	impressive	longevity	during	
periods	of	starvation,	allowing	them	to	survive	for	many	years	while	harbouring	the	
infectious	spirochaetes.	The	typical	argasid	tick	life	cycle	is	depicted	in	Figure	2.	
Some	species	that	fall	within	the	relapsing	fever	group	have	not	been	associated	
with	human	infection,	but	instead	cause	febrile	infection	among	food‐producing	
livestock.	These	zoonotic	agents	include	B.	anserina,	the	cause	of	avian	borreliosis	
transmitted	by	Argas	persicus	ticks,	and	B.	theileri,	the	agent	of	bovine	borreliosis	
transmitted	by	Rhipicephalus	tick	species,	B.	coriaceae	transmitted	to	deer	and	cattle	by	
O.	hermsi	ticks	among	others	34‐37.	It	is	highly	probable	that	other	livestock‐related	
species	exist	37,38	and	that	a	plethora	of	other	relapsing	fever‐related	Borrelia	persist	
amongst	other	as	of	yet	undisclosed	wildlife	reservoirs	11,39‐41.	Study	of	these	borrelial	
species	remains	largely	neglected.	
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Undoubtedly,	poverty	is	a	main	contributory	factor	associated	with	increased	
risk	for	acquisition	of	a	relapsing	fever	infection.	Figures	3	and	4	portray	some	of	these	
risk	factors,	including	poor	housing	conditions	and	street	beggars,	which	are	at	
particular	risk	for	relapsing	fever.	Both	LBRF	and	TBRF	have	their	greatest	burden	
among	those	living	in	extreme	poverty,	who	are	often	unaware	of	or	unable	to	
undertake	the	appropriate	precautionary	measures	to	reduce	the	risk	of	infection	3.	
Those	living	in	close	proximity	to	ticks	or	vertebrate	reservoirs	are	at	additional	risk	for	
acquiring	TBRF	9,42.	With	increasing	industrialisation,	urban	homeless	populations	have	
seen	an	upsurge	in	clothing	lice	(Figures	5	and	6),	which	could	provide	new	clusters	of	
disease	if	infected	lice	are	introduced	into	permissive	regions	43.	Another	intriguing	
possibility	for	transmission	and	spread	beyond	the	confines	of	clothing	lice	arises	from	
the	similarity	between	head	and	clothing	lice	exemplified	by	the	overlapping	phylogeny	
of	clothing	lice	with	cytochrome	B	clade	A	of	head	lice,	“Pediculus	humanus	var	capitis”	
44,45.	Specifically,	this	raises	the	question	as	to	whether	head	lice	could	potentially	serve	
as	alternative	vectors	for	B.	recurrentis?	Individuals	co‐infested	with	both	types	of	lice	
have	revealed	the	presence	of	B.	recurrentis	in	head	lice,	however	role	of	head	lice	in	
transmission	requires	further	investigation	46.	This	is	further	supported	by	the	finding	
of	other	clothing	louse‐borne	infections	(Bartonella	quintana)	in	head	lice	from	
individuals	with	no	evidence	of	co‐infestation	with	both	ecotypes	of	P.	humanus	47‐49.	
Occupational	contact	with	tick‐infested	environments	has	resulted	in	clusters	of	
TBRF	infection.		For	example,	among	military	personnel	in	Israel	who	used	caves	during	
training	activities,	approximately	6.4	cases	of	TBRF	occurred	per	100,000	individuals	50.	
Similarly,	environmental	conservation	workers	in	endemic	areas	are	also	at	risk	of	
infection.	Imported	cases	have	been	encountered	through	migration	and	tourism	where	
clinical	suspicion	in	non‐endemic	regions	may	not	be	as	heightened	to	“exotic”	
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infections	51‐54.	Several	clusters	and	sporadic	infections	have	also	been	traced	back	to	
vacation	destinations	in	rural	regions	where	intermittently	used	accommodations	
provide	refuge	for	reservoir	hosts	and	their	associated	tick	vectors	55.	
	
Epidemiology	
The	relapsing	fever	spirochaetes	have	historically	been	divided	into	Old	and	New	
World	species,	however	with	improving	phylogenetic	tools,	this	division	now	appears	
rather	artificial.	The	prevalence	of	tick	borne	strains	does	show	correlation	with	clearly	
demarked	regions,	as	is	particularly	evident	for	African	TBRF,	and	probably	resulted	
from	climatic	conditions	conducive	for	the	specific	tick	vector	56.	This	has	not	been	the	
case	for	the	louse‐borne	B.	recurrentis,	which	was	formerly	worldwide,	but	is	now	
restricted	to	areas	where	clothing	lice	persist	3,57.		
What	is	becoming	increasingly	apparent,	however,	is	the	burden	of	relapsing	
fever	infections	occurring	in	endemic	regions,	many	of	which	go	undiagnosed	or	
misdiagnosed	as	malaria	4,58‐60.	Recent	reports	from	Senegal	have	suggested	that	
relapsing	fever	borreliae	are	the	cause	of	approximately	13%	of	fevers	presenting	at	
local	dispensaries,	representing	an	alarming	11	to	25	cases	per	100	person	years	61.	
Studies	of	febrile	patients	in	Morocco	have	suggested	that	20.5%	were	due	to	TBRF	62.	
Although	not	at	such	high	levels,	TBRF	cases	are	more	frequently	being	detected	in	the	
USA	63,64.	Given	such	data,	despite	consideration	of	relapsing	fever	is	a	neglected	
disease,	it	certainly	should	not	be	forgotten.	
The	epidemiology	of	LBRF	has	changed	drastically	over	recent	years,	with	the	
demise	of	this	once	worldwide	infection	correlated	directly	with	the	reduced	level	of	
infestation	with	clothing	lice	65.	LBRF	remains	endemic	in	areas	of	extreme	poverty	such	
as	in	Ethiopia,	at	times	spreading	into	adjacent	regions,	such	as	Sudan.		
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Pathogenesis	
The	pathogenesis	of	relapsing	fever	spirochaetes	is	poorly	understood,	though	
the	release	of	host	cytokines	is	thought	to	play	a	major	role.	Production	of	IL‐10	by	the	
host	can	have	a	huge	influence	on	clinical	outcome	demonstrating	protection	against	
microvascular	injury	and	apoptosis	of	innate	immune	mediators,	but	conversely	can	
slow	antibody‐mediated	clearance	of	spirochaetes	66.	The	borreliae,	including	those	
associated	with	relapsing	fever,	are	relatively	neurotropic	and	their	sequestration	
within	the	central	nervous	system	provides	an	ideal	refuge	from	which	new	antigenic	
variants	can	reseed	the	circulatory	system	67.	Animal	experimental	studies	reported	
survival	of	borreliae	months	to	years	post‐infection	underscoring	the	ability	of	these	
spirochaetes	to	reside	within	the	brain.	
Finally,	the	expressed	surface	Vmps	play	a	pivotal	role	in	pathogenesis.	Some	
animal	studies	have	shown	correlation	of	particular	clinical	manifestations,	for	example	
high	blood	counts	versus	neurological	infection	with	the	expression	of	different	Vmps	of	
the	same	B.	turicatae	relapsing	fever	spirochaete	(see	microbiology	section)	68‐71.		Vmp	
proteins	play	a	major	role	in	the	ability	of	these	spirochaetes	to	maintain	high	blood	
densities	in	their	vertebrate	host	sometimes	reaching	levels	of	107	organisms	per	ml	of	
blood.	This	is	augmented	through	a	gene	conversion	mechanism	of	antigenic	variation	
that	generate	serotype	switching	and	thus	an	intricate	means	of	immunological	evasion	
72.	This	is	further	aided	by	the	ability	of	borreliae	to	find	serum	factors	such	as	factor	H	
and	factor	H‐like	proteins	73,74.	
	
Clinical	features	
Transmission	of	tick‐borne	relapsing	fever	follows	the	bite	of	an	infected	tick	
whilst	louse‐borne	infection	ensues	following	inoculation	of	crushed	lice	or	their	faeces	
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into	breaks	in	the	skin	such	as	through	scratching.	Unlike	the	transmission	of	Lyme	
disease	borreliae	that	require	attachment	of	their	tick	vector	for	an	excess	of	48	hours,	
transmission	of	tick‐borne	relapsing	fever	borreliae	is	rapid	and	has	been	demonstrated	
in	murine	models	to	be	possible	in	just	15	seconds	using	transmission	of	B.	turicatae	by	
its	O.	turicata	tick	vector.	This	is	largely	a	result	of	effective	spirochaetal	colonisation	of	
the	lumen	of	saliva‐producing	acini	and	possibly	also	the	excretory	ducts	with	
spirochaetes	facilitating	rapid	and	effective	delivery	of	borreliae	upon	initiation	of	tick	
feeding.	Typically	argasid	ticks	feed	nocturnally	with	attachment	times	of	5	minutes	to	2	
hours	being	reported	(average	feeding	time	of	approximately	20	minutes)	and	the	tick	
taking	up	2‐6	times	its	original	body	weight	in	blood.		
Following	an	incubation	period	of	3	to10	days,	patients	typically	develop	an	
abrupt	onset	of	fever	and	chills.	The	duration	of	febrile	episodes	may	vary,	but	will	
generally	subside	in	3‐5	days.		This	is	followed	by	an	afebrile	period	that	lengthen	as	the	
disease	progresses	interspersed	by	further	febrile	episodes.	Individuals	with	LBRF	may	
have	3‐5	febrile	episodes,	whilst	those	with	TBRF	may	have	up	to	13	recurrences	of	
fever	if	left	untreated.	Each	febrile	episode	correlates	with	a	change	in	the	surface	Vmp	
antigens	of	the	spirochaete,	whilst	clearance	is	associated	with	development	of	a	
specific	immunological	IgM	response	to	the	preceding	borrelial	serotype.	The	severity	
of	these	febrile	periods	generally	reduces	with	time,	however	organ	involvement	can	
complicate	clinical	recovery.		
The	most	severe	cases	of	disease	are	generally	attributed	to	the	human‐adapted	
species,	B.	recurrentis	and	B.	duttonii.		Cases	of	LBRF	typically	present	with	fever,	
headache,	hepatosplenomegaly,	joint	and	body	pains,	and	are	often	accompanied	by	
abdominal	tenderness,	jaundice	and	epistaxis75‐77.	Thrombocytopenia	and	renal	
impairment	are	common	features	following	infection	with	B.	recurrentis.	Major	organ	
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involvement	of	the	brain,	liver,	lungs	and	spleen	result	in	a	poor	prognosis,	with	death	
associated	with	hepatic	damage,	cardiac	failure,	lobar	pneumonia,	subarachnoid	
haemorrhage	or	splenic	rupture.	The	factors	that	predispose	to	poor	clinical	outcomes	
are	poorly	resolved,	but	are	likely	to	involve	the	complex	interplay	between	both	host	
and	microbial	factors.	The	clinical	manifestation	of	TBRF	infections	is	largely	dependent	
on	the	infecting	Borrelia	species	and	can	range	from	a	severe	febrile	disease	similar	to	
that	described	for	LBRF	as	seen	with	B.	duttonii	infection,	to	a	fairly	mild	febrile	illness	
without	associated	mortality	as	seen	for	infection	with	B.	crocidurae.	Some	species	are	
associated	with	particular	clinical	correlates,	such	as	B.	duttonii	and	its	adverse	
pregnancy	outcomes	whilst	epistaxis	and	jaundice	are	typically	clinical	features	of	B.	
recurrentis	infection.	Historically	this	clinical	variability	and	differential	severity	has	
been	used	as	a	means	of	speciation	through	use	of	animal	infection	models	(see	
diagnostic	section),	but	the	biological	basis	remains	poorly	resolved.	
	
Treatment	and	prognosis	
Management	of	clinical	cases	is	generally	achieved	with	use	of	penicillin	or	
doxycycline/tetracycline.	Sometimes	these	are	used	in	sequence	with	penicillin	being	
followed	by	doxycycline	as	this	might	reduce	the	occurrence	of	potentially	life‐
threatening	Jarisch‐Herxheimer	reactions	(JHR).	This	anecdotal	observation	has	been	
substantiated	by	meta‐analysis	findings	that	showed	more	rapid	clearance	with	
tetracycline,	but	also	a	higher	risk	of	JHRs,	whilst	mortality	rates	were	similar	between	
the	two	treatment	regimens	78.	The	JHR	is	a	“therapeutic	shock”	reaction	that	occurs	
within	24	hours	of	the	start	of	therapy	and	is	associated	with	a	dramatic	worsening	of	
clinical	symptoms	in	approximately	5%	of	cases.	This	is	believed	to	occur	through	a	
pronounced	release	of	pyrogenic	cytokines	with	significant	elevation	of	tumour	
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necrosis	factor‐alpha	and	interleukins	IL‐6	and	IL‐8	79.	Indeed,	some	have	reported	
benefit	from	use	of	anti‐TNF‐alpha	80.	Although	some	studies	have	documented	use	of	
single‐dose	therapeutic	regimes,	more	commonly	antimicrobials	are	given	for	7	to	14	
days.	Table	2	details	some	of	the	more	commonly	used	treatment	dosages	and	
regimes.81		
Mortality	rates	vary	with	the	infecting	agent,	with	most	TBRF	cases	having	less	
than	5%	mortality.	Mortality	can	be	higher	however	with	the	East	African	species,	B.	
duttonii	and	its	louse‐borne	variant,	B.	recurrentis.	Particularly	high	perinatal	mortality	
rates	reaching	475	cases/1000	pregnant	women	have	been	reported	from	Tanzania	
where	B.	duttonii	is	endemic.		Notably,	higher	spirochaetal	loads	are	reported	among	
pregnant	individuals	compared	to	non‐pregnant	controls	82.		Life‐long	protection	post‐
infection	does	not	appear	to	be	the	norm	with	repeat	infections	being	reported	amongst	
individuals	residing	in	endemic	regions.	
	
Diagnostic	methods	
Microscopy	
Though	refractory	to	visualisation	by	Gram‐staining,	these	spirochaetes	can	be	
stained	using	Giemsa,	Wright’s	stain	or	silver‐staining	methods	(Figure	7).	Darkfield	or	
phase	microscopy	can	be	used	for	freshly	collected	blood	or	CSF	if	available	(or	to	check	
results	of	cultivation	or	following	animal	inoculation),	enabling	observation	of	the	
highly	motile	spirochaetes.	Assessment	of	ticks	for	infection	has	used	salivary	glands,	
haemolymph	extracted	post	leg	amputation	or	whole	tick	preparations.	Whilst	these	
methods	can	detect	Borrelia,	sensitivity	is	poor	requiring	in	excess	of	105	organisms	per	
millilitre	for	detection,	particularly	challenging	for	some	species	such	as	B.	crocidurae,	
for	which	the	blood	burden	is	lower	than	for	example	B.	recurrentis.	Use	of	thick	blood	
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films	can	improve	sensitivity	where	numbers	are	low,	but	alternative	methods	such	as	
molecular	detection	might	provide	more	reliable	data	where	sensitivity	is	a	priority.	
This	is	further	complicated	by	the	need	to	collect	blood	during	febrile	episodes.	An	
additional	limitation	of	direct	microscopy	is	the	inability	to	differentiate	the	causative	
species.	
		
Animal	inoculation	
Animal	inoculation,	particularly	use	of	small	rodents,	was	popular	both	for	its	
ability	to	recover	cultivable	strains	83	and	to	identify	these	agents	through	comparative	
virulence	studies	(mice	and	guinea	pigs)	8.	Although	not	now	routinely	undertaken,	this	
technique	is	currently	largely	restricted	to	specialist	institutes	where	it	remains	useful	
for	recovery	of	primary	isolates.	On	a	cautionary	note,	it	must	be	remembered	that	
some	species,	such	as	B.	recurrentis,	are	refractory	to	growth	in	rodent	models,	but	can	
be	isolated	in	primate	models.	Use	of	immunocompromised	SCID	mice	to	overcome	this	
limitation	was	met	with	mixed	success,	with	only	low	level	infection	being	achieved	84.		
	
Cultivation	
Isolation	of	relapsing	fever	borreliae	can	also	be	achieved	in	culture	by	directly	
innoculating	clinical	samples	into	specialised	liquid	media	(such	as	BSKII	or	MKP).	
However,	the	fastidious,	slow‐growing	nature	of	these	spirochaetes	makes	this	
technically	demanding	85‐87.	Not	all	batches	of	commercially‐produced	medium	support	
growth	equally	well	and	consequently	batch	testing	of	media	should	be	employed.	In	
cases	of	culture	contamination,	inclusion	of	antimicrobials	such	as	rifampicin,	colistin	
sulphate,	aninoglycosides	or	antifungals	can	be	used	to	help	purify	isolates.	
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Alternatively,	the	slender	Borrelia	morphology	enables	purification	of	contaminated	
cultures	through	filtration.	
On	a	cautionary	note,	not	all	species	or	strains	appear	uniformly	cultivable	12.	
Until	the	1990’s,	B.	recurrentis	and	B.	duttonii	were	deemed	non‐cultivable	until	isolates	
were	successfully	recovered	using	BSKII	medium	88‐90.	Despite	the	successful	isolation	
of	B.	duttonii,	comparison	of	genotypes	recovered	by	cultivation	and	those	detected	by	
PCR/sequencing	directly	from	ticks,	revealed	that	all	cultivable	isolates	belonged	to	
only	one	of	the	four	genotypic	groups	prevalent	in	the	study	area	12.	
	
Serological	detection	
Specific	antigens,	including	GlpQ	or	BipA,	have	been	identified	which	are	shared	
by	all	relapsing	fever	group	spirochaetes,	but	are	absent	from	Borrelia	species	
associated	with	Lyme	disease,	thus	precluding	serologic	cross‐reactions	between	these	
borreliae	91,92.	These	antigens	have	been	used	successfully	in	enzyme‐linked	
immunoassays	to	enable	serological	diagnosis	or	population	screening.	Such	assays	
have	not	been	produced	commercially	however	as	they	would	have	little	value	in	highly	
endemic	regions,	and	the	sporadic	nature	of	imported	cases	makes	commercialisation	
financially	non‐viable.	
	
Molecular	detection	
Molecular	detection	and	identification	approaches	offer	distinct	advantages	over	
the	recovery	of	these	fastidious	microbes	and	has	become	the	mainstay	for	both	
detection	and	typing	of	relapsing	fever	Borrelia.	Various	conserved	targets,	such	as	16S	
rRNA	and	flagellin	(flaB)	genes,	have	been	used	for	diagnosis,	but	lack	discriminatory	
power	for	typing	37,93,94.	Availability	of	genomic	sequence	data	has	enabled	development	
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of	single	nucleotide	polymorphism	(SNP)	based	multiplex	identification	methods	and	
highly	discriminatory	multi‐spacer	typing	methods	95,96.	It	must	be	remembered	that	
these	assays	may	not	always	detect	newly	described	species.	Use	of	16S‐23S	ribosomal	
intragenic	spacer	region	sequencing	has	provided	a	highly	discriminatory	means	of	
delineating	strains	12.	Application	of	these	high‐resolution	methods	has	enabled	
scrutiny	of	the	genotypes	circulating	in	specific	enzoonotic	regions	and	correlation	with	
tick	and	vertebrate	species	4.	
	
Proteomics	
Although	the	application	of	proteomics	for	detection	of	relapsing	fever	
borreliosis	is	in	its	infancy,	this	is	an	exciting	potential	application.	Differences	in	
proteomic	profiles	have	been	detected,	differentiating	tick	haemolymph	derived	from	
Borrelia‐infected	ticks	compared	to	their	uninfected	counterparts.	This	could	provide	a	
more	cost‐effective	means	of	screening	ticks	for	carriage	of	relapsing	fever	spirochaetes	
97.	
	
Control	and	Intervention	
Relapsing	fever	spirochaetes	currently	remain	exquisitely	susceptible	to	
antimicrobials	including	penicillin,	tetracycline/doxycycline,	chloramphenicol,	
ceftriaxone	and	erythromycin.	Wide	use	of	antimicrobials	coupled	with	improvements	
in	living	conditions,	particularly	in	areas	where	relapsing	fever	has	its	reservoir	in	
humans,	such	as	LBRF	in	Ethiopia,	has	been	correlated	with	a	declining	incidence	of	
infection	65.		
This	is	not	so	apparent	for	the	tick‐borne	forms	of	disease	that	persist	in	their	
longer‐lived	tick	vector/reservoirs	and	through	the	zoonotic	vertebrate	reservoirs.	The	
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burden	of	TBRF	among	subsistence	agro‐pastoralist	communities	in	developing	nations	
remains	substantial.	Use	of	acaracides	(including	arsenicals,	chlorinated	hydrocarbons,	
organophosphates,	carbamates	and	synthetic	pyrethroids)	has	been	met	with	some	
success,	though	costs	are	prohibitive	in	many	areas	that	would	benefit	from	use	of	such	
measures	and	the	environmental	consequences	of	their	use	should	not	be	overlooked	
98,99.	Biological	controls	have	been	explored	with	entomopathic	fungi	showing	some	
success	against	ixodid	ticks,	but	control	of	argasid	ticks	has	been	largely	neglected	100‐
102.	
Prohibiting	access	to	high‐risk	areas	has	successfully	reduced	disease	incidence	
in	areas	endemic	for	B.	persica	in	Israel	where	significant	levels	of	infection	occurred	
among	military	personnel	whilst	utilising	tick‐infested	caves	during	training.	If	contact	
is	unavoidable,	doxycline	prophylaxis	has	been	used	for	short‐term	prevention	103.		
Given	the	limitations	of	acaricides	to	reduce	the	burden	of	infection,	other	
options	such	as	immunological	controls	have	also	been	explored.		These	measures	have	
been	used	to	reduce	relapsing	fever	and	indeed	other	pathogens	vectored	by	the	same	
tick	species,	such	as	African	swine	fever	virus,	a	haemorrhagic	febrile	infection	of	swine	
with	a	mortality	rate	approaching	100%.	Control	at	the	level	of	the	vector	is	
consequently	an	attractive	prospect.	Again,	anti‐tick	vaccines	against	ixodid	ticks	have	
led	the	way,	with	commercial	vaccines	against	Rhipicephalus	microplus	being	marketed	
in	Australia	and	Latin	America	99.	Analysis	of	both	the	gut	transcriptome	and	proteome	
of	argasid	ticks	is	an	essential	prerequisite	for	the	development	of	such	vaccine	
candidates.	Whether	these	potential	vaccines	would	be	directed	primarily	towards	
protection	of	livestock	or	companion	animals	from	tick‐borne	infection,	or	whether	a	
“one	health”	approach,	whereby	reduction	of	ticks	through	protection	of	their	
vertebrate	hosts	would	indirectly	reduce	human	infections,	remains	to	be	resolved.	
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Concluding	remarks	
The	relapsing	fever	Borrelia	have	a	long	and	notorious	history,	from		being	one	of	
the	earliest	bacterial	infectious	diseases	described	associated	with	high	mortality	and	
morbidity,	through	to	a	period	of	neglect.	This	in	part	was	a	result	of	the	demise	of	the	
clothing	louse	and	hence	also	LBRF,	through	improved	hygiene,	living	conditions	and	
use	of	DDT.	Similarly,	improvements	in	housing	have	reduced	contact	between	soft	ticks	
and	humans,	except	in	areas	of	poverty.	Despite	these	global	reductions	in	relapsing	
fever,	endemic	regions	persist	and	detection	of	cases	is	often	sub‐optimal.	Clinical	
overlap	with	malaria	and	use	of	suboptimal	diagnostic	methods	for	relapsing	fever	
agents,	hamper	the	detection	of	this	treatable	infection.	
Despite	this	neglect,	application	of	improved	methods	for	detection,	typing	and	
cultivation	of	these	spirochaetes	has	allowed	us	to	gain	intriguing	insights	into	the	
biology	of	these	organisms.	Newly	described	species,	and	deeper	understanding	of	the	
previously	established	members	of	this	group	will	help	us	dissect	evolutionary	and	
ecological	relationships.	Greater	insights	into	the	mechanisms	of	pathogenesis	and	
strategies	employed	to	evade	the	immune	defences	of	the	vertebrate	host	will	provide	
future	research	goals.	 	
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	Figure	Legends	
Figure	1:	Ornithodoros	moubata	tick.	
	
Figure	2:	Life	cycle	of	Ornithodoros	moubata	ticks,	the	vector	of	B.	duttonii.	
	
Figure	3:	Ethiopian	dwelling.	
	
Figure	4:	Street	beggar	in	Ethiopia.	
	
Figure	5:	Pediculus	humanus	clothing	lice	showing	adult	and	sub‐adult	stages.	
	
Figure	6:	Pediculus	humanus	clothing	lice	showing	eggs	cemented	to	clothing	and	
recently	hatched	lice.	
	
Figure	7:	Blood	film	showing	Giemsa‐staining	magnification	x400.	
	
Table	1:	Relapsing	fever	group	species,	their	vectors	and	geographical	location.	
	
Table	2:	Treatment	options	commonly	used	for	relapsing	fever	management.
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